Loading clinical trials...
Loading clinical trials...
Evaluation in Real Life Conditions of Sacubitril-valsartan Combination in Patients With Chronic Heart Failure and Sleep Apnea Syndrome
Conditions
Interventions
SACUBITRIL - VALSARTAN (formerly LCZ696, ENTRESTO®)
Locations
6
France
CHU Bordeaux
Bordeaux, Pessac, France
Pôle médical spécialisé MSP
Béziers, France
CHU Béziers
Béziers, France
Centre Hospitalier Universitaire de Montpellier
Montpellier, France
CHU Nimes
Nîmes, France
CHU Toulouse
Toulouse, France
Start Date
September 22, 2016
Primary Completion Date
February 27, 2020
Completion Date
February 27, 2020
Last Updated
June 15, 2021
NCT07357272
NCT06019169
NCT07325942
NCT05934565
NCT06706791
NCT04399200
Lead Sponsor
University Hospital, Montpellier
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions